Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of 3 Marketed Guaifenesin Products in Healthy Subjects
NCT03643575Phase 1Completed
- Sponsor
- Reckitt
- Start
- Jun 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of guaifenesin in cough (3 arms), sponsored by Reckitt. Primary endpoints: Maximum Observed Plasma Concentration, Maximum Measured Plasma Concentration at Steady State and 14 more. Started Jun 2009; status: completed.
02
Drugs
guaifenesin
03
Conditions
cough
Beyond the preview
Go deeper on NCT03643575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03643575.